Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sunflower Pharmaceutical Group Hubei Wudang is a key manufacturing subsidiary of the Sunflower Pharmaceutical Group, located in Danjiangkou, Hubei Province. The company specializes in the production of Traditional Chinese Medicines (TCM) and chemical drugs, with a significant focus on pediatric health, respiratory treatments, and digestive care. Operating from modern, GMP-certified facilities, it leverages the rich medicinal herb resources of the Wudang Mountain region to produce a diverse portfolio of over-the-counter (OTC) and prescription medications. The entity was integrated into the Sunflower Group in 2014, strengthening the parent company's supply chain and market presence in central China. Its products are widely distributed through the group's extensive national retail network, serving millions of patients across the country.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sunflower Pharmaceutical Group Hubei Wudang.